期刊文献+

2012-2013流感监测年度中国大陆B型流感病毒抗原性及基因特性分析 被引量:31

Antigenic and genetic characteristics of influenza B virus in the mainland of China,2012- 2013
原文传递
导出
摘要 目的了解2012-2013流感监测年度中国大陆地区B型流感的流行状况,分析B型流感病毒的抗原性和基因变异情况。方法选择2012-2013年我国分离的B型流感病毒,利用标准雪貂抗血清进行抗原性分析。利用Sanger测序法进行病毒基因测序,采用Neighbor-Joining方法进行种系进化分析,通过基因进化树比较国内流行株与疫苗株的差异。结果 2012-2013监测年度内,B型流感病毒占所有流感病毒的9.93%,其中以B型Victoria系流感病毒为主。B型Victoria系流感病毒的抗原性与上一年度WHO推荐的疫苗株B/Brisbane/60/2008(83.5%)以及我国代表株B/Chongqing-Yuzhong/1384/2010(94.7%)的抗原性类似;而B型Yamagata系流感病毒绝大多数为WHO疫苗株B/Wisconsin/01/2010(99.3%)、WHO疫苗种子株B/Hubei-Wujiagang/158/2009(98.0%)的类似株;基因特性分析显示有1株B-Victoria系病毒发生了HA与NA基因分支间的重配,有1株B-Yamagata系病毒B/Sichuan-Gaoxin/1110/2012的NA基因位于Victoria系病毒的NA进化分支,也表明发生了种系间的基因重配。结论 2012-2013流感监测年度我国B型流感病毒活动水平较低,主要以Victoria系为主,而WHO推荐的疫苗组分是B-Yamagata系病毒,可见部分B型流感流行株与疫苗株并不匹配。 Objective To understand the epidemiological characteristics of influenza B and the antigenic and genetic characteristics of influenza B virus in the mainland of China during 2012 - 2013. Methods The antigenic characteristics of influenza B virus was analyzed with reference ferret anti-sera. The nucleotide sequences of the influenza B viruses were determined by Sanger dideoxy sequencing. The phylogenetic trees were constructed by neighbor-jointing method, the genetic characteristics were determined and compared the circulating influenza B virus with current vaccine strains. Results During 2012 - 2013 influenza season influenza B virus accounted for 9.93% of total influenza viruses detected, the activity of B Victoria lineage virus were stronger than B Yamagata lineage virus. Most B Victoria lineage viruses had close antigenic relation with the vaccine strain B/Brisbane/6012008 (83.5% ) recommended by WHO in previous year and the representative circulating strain B/Chongqing- Yuzhong/1384/2010 (94.7%) in the mainland of China. The majority of B Yamagata lineage viruses had closely antigenic relation with WHO recommended vaccine strain B/Wisconsin/01/2010 ( 99. 3%) and WHO vaccine seed B/Hubei-Wujiagang/158/2009 ( 98. 0% ); phylogenetic analysis on B Victoria lineage viruses indicated that one strain had intra-clade reassortants between HA and NA gene. One of the B Yamagata lineage viruses, B/Sichuan-Gaoxin/1110/2012, was confirmed to be an intra-lineage reassortant with NA gene from B Victoria lineage. Conclusion The activity of B Victoria lineage virus was stronger than Yamagata lineage virus in the mainland of China during 2012 -2013 influenza season, but only Yamagata lineage virus was included in the WHO recommended trivalent influenza vaccine for this period, which could not provide protection to B Victoria lineage virus infection.
出处 《疾病监测》 CAS 2014年第1期14-20,共7页 Disease Surveillance
基金 国家科技重大专项课题(No.2013ZX10004-101)
关键词 B型流感病毒 抗原性 基因特性 influenza B antigenic characteristics genetic characteristics
  • 相关文献

参考文献8

  • 1Yu H,Feng L,Viboud CG. Regional variation in mortality impact of the 2009 A(H1N1)influenza pandemic in China[J].Influenza Other Respir Viruses,2013,(06):1350-1360.
  • 2WHO. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season[J].{H}Weekly Epidemiological Record,2012,(10):81-96.
  • 3Rota PA,Wallis TR,Harmon MW. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983[J].{H}VIROLOGY,1990,(01):59-68.
  • 4Belshe RB,Coelingh K,Ambrose CS. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity[J].{H}VACCINE,2010,(09):2149-2156.
  • 5郭元吉;程小雯.流行性感冒病毒及其实验技术[M]{H}北京:中国三峡出版社,1997.
  • 6Sheu TG,Deyde VM,Garten R J. Detection of antivirai resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing[J].{H}Antiviral Research,2010,(02):354-360.
  • 7Jackson D,Barclay W,Zurcher T. Characterization of recombinant influenza B viruses with key neurarmnidase inhibitor resistance mutations[J].{H}Journal of Antimicrobial Chemotherapy,2005,(02):162-169.
  • 8Sleeman K,Sheu TG,Moore Z. Influenza B viruses with mutation in the neuraminidase active site,North Carolina,USA,2010-11[J].{H}EMERGING INFECTIOUS DISEASES,2011,(11):2043-2046.

同被引文献203

引证文献31

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部